Ceragenix Pharmaceuticals, Inc. Reports 2005 Year-End Financial Results And Business Progress

March 27, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

DENVER--(BUSINESS WIRE)--March 27, 2006--Ceragenix Pharmaceuticals, Inc., (OTCBB: CGXP), a biopharmaceutical company focused on infectious disease and dermatology, today announced financial results for the full-year ended December 31, 2005.

Twitter
LinkedIn
Facebook
Email
Print

Earnings